Clinical Trial Update: Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of apremilast in adults with moderate to severe atopic dermatitis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Dermatitis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Amgen | Conditions: Dermatitis, Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2016-12-12